HWP
NVO

Highline Wealth Partners’s Novo Nordisk NVO Stock Holding History

Highline Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9K Buy
520
+25
+5% +$1.07K 0.01% 357
2026
Q1 		$18.2K Buy
495
+43
+10% +$2.04K ﹤0.01% 316
2025
Q4 		$23K Sell
452
-83
-16% -$4.24K 0.01% 234
2025
Q3 		$29.7K Sell
535
-9
-2% -$527 0.01% 211
2025
Q2 		$37.5K Sell
544
-39
-7% -$2.65K 0.01% 159
2025
Q1 		$40.5K Hold
583
– – 0.01% 148
2024
Q4 		$50.1K Sell
583
-1,810
-76% -$196K 0.02% 130
2024
Q3 		$285K Sell
2,393
-64
-3% -$8.54K 0.1% 89
2024
Q2 		$351K Buy
2,457
+679
+38% +$90K 0.13% 83
2024
Q1 		$228K Buy
1,778
+1,378
+345% +$164K 0.09% 95
2023
Q4 		$41.4K Hold
400
– – 0.02% 134
2023
Q3 		$36.4K Buy
+400
New +$35.2K 0.02% 124

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return

Highline Wealth Partners's NVO Position: Q2 2026 in Review

Highline Wealth Partners increased its Novo Nordisk (NVO) stake by 5.1% in Q2 2026, buying an estimated $1.07K and bringing the position to 520 shares worth $24.9K. The position accounts for 0.01% of the portfolio, ranked #357.

Highline Wealth Partners first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $351K in Q2 2024. 270 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Highline Wealth Partners held 520 shares of Novo Nordisk worth $24.9K as of Q2 2026.
  • Highline Wealth Partners bought 25 Novo Nordisk shares in Q2 2026, an estimated $1.07K.
  • Novo Nordisk made up 0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #357 holding.
  • Highline Wealth Partners first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
  • Highline Wealth Partners's Novo Nordisk position peaked at $351K in Q2 2024.
  • 270 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.